Alnylam Pharmaceuticals Reports Second Quarter 2008 Financial Results

August 6, 2008 |

1 min read

Twitter
LinkedIn
Facebook
Email
Print

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), a leading RNAi therapeutics company, today reported its consolidated financial results for the second quarter of 2008, and company highlights.

Twitter
LinkedIn
Facebook
Email
Print

Earnings

Alnylam Pharmaceuticals